F Dx Advisors, Inc. Danaher Corp Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

A detailed history of F Dx Advisors, Inc. transactions in Danaher Corp stock. As of the latest transaction made, F Dx Advisors, Inc. holds 886 shares of DHR stock, worth $208,954. This represents 0.07% of its overall portfolio holdings.

Number of Shares

886

Previous 846 4.73%

Holding current value

$208,954

Previous $211,000 16.59%

% of portfolio

0.07%

Previous 0.06%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$239.25 - $280.76 $9,570 - $11,230	40 Added 4.73%	886 $246,000
Q2 2024 Aug 02, 2024	SELL	$235.51 - $267.98 $10,833 - $12,327	-46 Reduced 5.16%	846 $211,000
Q1 2024 May 03, 2024	SELL	$224.58 - $256.19 $218,965 - $249,785	-975 Reduced 52.22%	892 $223,000
Q4 2023 Feb 12, 2024	SELL	$185.1 - $233.13 $115,132 - $145,006	-622 Reduced 24.99%	1,867 $432,000
Q3 2023 Nov 02, 2023	SELL	$233.08 - $265.59 $361,507 - $411,930	-1,551 Reduced 38.39%	2,489 $617,000
Q2 2023 Jul 17, 2023	BUY	$224.99 - $256.14 $363,583 - $413,922	1,616 Added 66.67%	4,040 $969,000
Q4 2022 Feb 09, 2023	SELL	$241.42 - $282.29 $258,319 - $302,050	-1,070 Reduced 30.62%	2,424 $643,000
Q3 2022 Nov 10, 2022	BUY	$247.06 - $1507.4 $25,447 - $155,262	103 Added 3.04%	3,494 $902,000
Q2 2022 Aug 03, 2022	SELL	$237.11 - $299.66 $490,106 - $619,397	-2,067 Reduced 37.87%	3,391 $860,000
Q1 2022 May 03, 2022	SELL	$257.27 - $315.76 $287,113 - $352,388	-1,116 Reduced 16.98%	5,458 $1.6 Million
Q4 2021 Feb 01, 2022	SELL	$292.08 - $329.01 $61,044 - $68,763	-209 Reduced 3.08%	6,574 $2.16 Million
Q3 2021 Oct 08, 2021	SELL	$272.21 - $332.43 $139,371 - $170,204	-512 Reduced 7.02%	6,783 $2.07 Million
Q2 2021 Aug 05, 2021	SELL	$225.08 - $271.69 $190,417 - $229,849	-846 Reduced 10.39%	7,295 $1.96 Million
Q1 2021 Apr 14, 2021	BUY	$212.38 - $245.9 $1.34 Million - $1.55 Million	6,309 Added 344.38%	8,141 $1.83 Million
Q1 2021 Apr 13, 2021	SELL	$212.38 - $245.9 $1.56 Million - $1.8 Million	-7,330 Reduced 80.0%	1,832 $412,000
Q4 2020 Feb 08, 2021	SELL	$212.5 - $245.46 $2,125 - $2,454	-10 Reduced 0.11%	9,162 $2.04 Million
Q3 2020 Nov 12, 2020	SELL	$177.16 - $215.33 $341,564 - $415,156	-1,928 Reduced 17.37%	9,172 $1.98 Million
Q2 2020 Jul 22, 2020	BUY	$128.7 - $176.83 $86,357 - $118,652	671 Added 6.43%	11,100 $1.96 Million
Q1 2020 May 22, 2020	SELL	$121.39 - $169.05 $181,963 - $253,405	-1,499 Reduced 12.57%	10,429 $1.44 Million
Q1 2020 May 13, 2020	BUY	$121.39 - $169.05 $168,974 - $235,317	1,392 Added 13.21%	11,928 $1.14 Million
Q4 2019 Feb 12, 2020	BUY	$133.47 - $153.48 $94,630 - $108,817	709 Added 7.21%	10,536 $1.62 Million
Q3 2019 Nov 07, 2019	SELL	$135.4 - $146.47 $1.37 Million - $1.48 Million	-10,105 Reduced 50.7%	9,827 $1.42 Million
Q2 2019 Jul 19, 2019	BUY	$124.88 - $143.73 $556,090 - $640,029	4,453 Added 28.77%	19,932 $2.85 Million
Q1 2019 May 14, 2019	SELL	$97.62 - $132.29 $274,995 - $372,660	-2,817 Reduced 15.4%	15,479 $2.04 Million
Q4 2018 Apr 29, 2019	SELL	$94.85 - $109.54 $1.08 Million - $1.25 Million	-11,429 Reduced 38.45%	18,296 $1.89 Million
Q4 2018 Feb 07, 2019	BUY	$94.85 - $109.54 $677,229 - $782,115	7,140 Added 31.61%	29,725 $3.07 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $348,361 - $386,595	3,550 Added 18.65%	22,585 $2.45 Million
Q2 2018 Aug 08, 2018	SELL	$96.1 - $103.24 $1.65 Million - $1.78 Million	-17,200 Reduced 47.47%	19,035 $1.88 Million
Q1 2018 May 02, 2018	BUY	$92.16 - $103.8 $8,847 - $9,964	96 Added 0.27%	36,235 $3.55 Million
Q4 2017 Feb 09, 2018	SELL	$85.26 - $94.62 $53,628 - $59,515	-629 Reduced 1.71%	36,139 $3.35 Million
Q3 2017 Nov 03, 2017	BUY	$79.29 - $88.45 $168,649 - $188,133	2,127 Added 6.14%	36,768 $3.15 Million
Q2 2017 Aug 11, 2017	BUY	N/A	34,641	34,641 $2.92 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account